CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Revenues	$ 10,576,473	$ 7,257,290
Cost of revenues	4,855,520	3,482,136
Gross profit	5,720,953	3,775,154
Operating expenses
Selling, general and administrative	3,827,324	2,704,949
Depreciation and amortization	502,376	333,761
Total operating expenses	4,329,700	3,038,710
Income from operations	1,391,253	736,444
Other income (expense)
Interest income	62,161	119,173
Total other income, net	62,161	119,173
Income before income tax benefit and noncontrolling interest	1,453,414	855,617
Income tax benefit	(87,551)	(15,490)
Net income before noncontrolling interest	1,540,965	871,107
Net loss attributable to the noncontrolling interest	0	564
Net income attributable to Paysign, Inc.	$ 1,540,965	$ 871,671
Net income per common share - basic	$ 0.03	$ 0.02
Net income per common share - fully diluted	$ 0.03	$ 0.02
Weighted average common shares outstanding - basic	48,713,163	49,961,079
Weighted average common shares outstanding - fully diluted	54,688,066	54,508,835
Plasma Industry [Member]
Revenues	$ 7,343,410	$ 5,884,577
Pharma industry [Member]
Revenues	3,020,377	1,372,713
Other [Member]
Revenues	$ 212,686	$ 0